Literature DB >> 1699539

The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2.

T Katagiri1, A Yamaguchi, T Ikeda, S Yoshiki, J M Wozney, V Rosen, E A Wang, H Tanaka, S Omura, T Suda.   

Abstract

The possibility that the non-osteogenic mouse pluripotent cell line, C3H10T1/2 (10T1/2), could be induced to differentiate into osteogenic cells by various hormones and cytokines was examined in vitro. Of a number of agents tested, recombinant human bone morphogenetic protein-2 (rhBMP-2) and retinoic acid induced alkaline phosphatase (ALP) activity in 10T1/2 cells. rhBMP-2 also induced mRNA expression of ALP in the cells. Dexamethasone, 1 alpha, 25-dihydroxyvitamin D3, transforming growth factor-beta 1 and insulin-like growth factor-I did not stimulate ALP activity. Treatment with rhBMP-2 greatly induced cAMP production in response to parathyroid hormone in 10T1/2 cells. No ALP activity was induced in NIH3T3 fibroblasts treated with rhBMP-2 or retinoic acid. These results indicate that 10T1/2 cells have a potential to differentiate into osteogenic cells under the control of BMP-2.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1699539     DOI: 10.1016/s0006-291x(05)80208-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  75 in total

1.  Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo.

Authors:  Helmut Glantschnig; Richard A Hampton; Ping Lu; Jing Z Zhao; Salvatore Vitelli; Lingyi Huang; Peter Haytko; Tara Cusick; Cheryl Ireland; Stephen W Jarantow; Robin Ernst; Nan Wei; Pascale Nantermet; Kevin R Scott; John E Fisher; Fabio Talamo; Laura Orsatti; Alfred A Reszka; Punam Sandhu; Donald Kimmel; Osvaldo Flores; William Strohl; Zhiqiang An; Fubao Wang
Journal:  J Biol Chem       Date:  2010-10-07       Impact factor: 5.157

2.  Development and characterization of a mouse floxed Bmp2 osteoblast cell line that retains osteoblast genotype and phenotype.

Authors:  Li-an Wu; Junsheng Feng; Lynn Wang; Yan-dong Mu; Andrew Baker; Kevin J Donly; Stephen E Harris; Mary MacDougall; Shuo Chen
Journal:  Cell Tissue Res       Date:  2011-01-27       Impact factor: 5.249

3.  Perlecan-stimulated nodules undergo chondrogenic maturation in response to rhBMP-2 treatment in vitro.

Authors:  Ronald R Gomes; Mary C Farach Carson; Daniel D Carson
Journal:  Connect Tissue Res       Date:  2003       Impact factor: 3.417

Review 4.  Adipose tissue stem cells meet preadipocyte commitment: going back to the future.

Authors:  William P Cawthorn; Erica L Scheller; Ormond A MacDougald
Journal:  J Lipid Res       Date:  2011-12-02       Impact factor: 5.922

Review 5.  Transplantation of skin fibroblasts expressing BMP-2 contributes to the healing of critical-sized bone defects.

Authors:  Kazunari Hirata; Akio Mizuno; Akira Yamaguchi
Journal:  J Bone Miner Metab       Date:  2007-01-01       Impact factor: 2.626

Review 6.  Mechanical modulation of osteochondroprogenitor cell fate.

Authors:  Melissa L Knothe Tate; Thomas D Falls; Sarah H McBride; Radhika Atit; Ulf R Knothe
Journal:  Int J Biochem Cell Biol       Date:  2008-05-24       Impact factor: 5.085

7.  Co-culture of canine mesenchymal stem cells with primary bone-derived osteoblasts promotes osteogenic differentiation.

Authors:  C Csaki; U Matis; A Mobasheri; M Shakibaei
Journal:  Histochem Cell Biol       Date:  2008-10-22       Impact factor: 4.304

8.  Perlecan: an important component of the cartilage pericellular matrix.

Authors:  R Gomes; C Kirn-Safran; M C Farach-Carson; D D Carson
Journal:  J Musculoskelet Neuronal Interact       Date:  2002-12       Impact factor: 2.041

9.  Effects of bone morphogenetic protein-2 and transforming growth factor beta1 on gene expression of transcription factors, AJ18 and Runx2 in cultured osteoblastic cells.

Authors:  Minoru Takagi; Naoko Kamiya; Tomihisa Takahashi; Shinsuke Ito; Mitsuharu Hasegawa; Naoto Suzuki; Koji Nakanishi
Journal:  J Mol Histol       Date:  2004-01       Impact factor: 2.611

10.  The CCN family member Wisp3, mutant in progressive pseudorheumatoid dysplasia, modulates BMP and Wnt signaling.

Authors:  Yukio Nakamura; Gilbert Weidinger; Jennifer O Liang; Allisan Aquilina-Beck; Keiko Tamai; Randall T Moon; Matthew L Warman
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.